---
{"dg-publish":true,"permalink":"/USMLE/GI/Autoimmune hepatitis/"}
---

# Epidemiology
---


# Etiology
---
- AIH is commonly associated with other autoimmune conditions
	- Type 1 AIH: [[USMLE/Endocrine/Hashimoto thyroiditis\|Hashimoto thyroiditis]], Grave disease, [[USMLE/GI/Ulcerative colitis\|ulcerative colitis]], [[USMLE/GI/Celiac disease\|celiac disease]], [[USMLE/MSK/Rheumatoid arthritis\|rheumatoid arthritis]]
	- Type 2 AIH: [[USMLE/Endocrine/Hashimoto thyroiditis\|Hashimoto thyroiditis]], [[USMLE/Endocrine/Diabetes mellitus\|type 1 diabetes]] mellitus, [[USMLE/MSK/Vitiligo\|vitiligo]]

# Pathophysiology
---

# Classification
---
- Type 1 AIH (80% of cases): characteristic autoantibodies include antinuclear antibodies (ANAs), anti-smooth muscle antibodies (ASMAs) anti-soluble liver antigen antibodies (anti-SLA)
- Type 2 AIH: characteristic autoantibodies include anti-liver-kidney microsomal-1 antibodies (anti-LKM-1), anti-liver cytosol antibodies-1 (ALC-1)

# Clinical features
---
![Pasted image 20231016163207.png](/img/user/appendix/Pasted%20image%2020231016163207.png)
- Nonspecific symptoms
	- Fatigue
	- Upper abdominal pain
	- Weight loss
- <span style="background:rgba(240, 200, 0, 0.2)">Signs of acute liver failure (∼ ⅓ of patients)</span>

# Diagnostics
---
## Laboratory tests 
- Liver chemistries: <span style="background:rgba(240, 200, 0, 0.2)">↑↑↑ ALT and ↑↑ AST</span>, ↑ GGT, normal or ↑ ALP, and ↑ bilirubin 
- Serum antibodies
	- <span style="background:rgba(240, 200, 0, 0.2)">ANA, ASMA: combination is highly specific for type 1 AIH </span>
	- Anti-LKM-1: typically positive in type 2 AIH
- SPEP: hypergammaglobulinemia (↑ IgG)
## Liver biopsy
- Histological findings: 
	- <span style="background:rgba(240, 200, 0, 0.2)">Lymphoplasmacytic interface hepatitis: ongoing inflammatory process with lymphocytic infiltration, bridging or multiacinar necrosis, and fibrotic changes</span>
	- Bile duct changes (e.g., cholangitis, ductal injury)

# Treatment
---

